Health tech company says it will dive into Medicare’s new chronic care experiment

March 9, 2026 - 12:52

A prominent remote patient monitoring company has announced a significant strategic pivot, restructuring its core technology to participate in a new Medicare experiment aimed at chronic care management. This move highlights the industry's shift toward value-based payment models, where reimbursement is tied directly to patient health outcomes rather than the volume of services provided.

The federal program, known as the Value-Based Insurance Design (VBID) Model, tests whether offering tailored benefits and reduced cost-sharing for Medicare Advantage enrollees with specific chronic conditions can lead to better health and lower costs. By adapting its platform, the tech firm aims to meet the stringent data reporting and care coordination requirements necessary for enrollment.

The company's recalibrated technology will focus on enhanced data collection, actionable patient insights for clinicians, and tools to demonstrate measurable improvements in patient health. This initiative represents a broader trend of digital health companies aligning their products with the healthcare system's evolving financial incentives. Success in this arena could pave the way for more widespread adoption of remote monitoring, offering a potential blueprint for managing chronic diseases more effectively while controlling costs. The industry will be watching closely to see if this fusion of technology and new payment structures delivers on its promise of higher-quality, more sustainable care.